Entrada Therapeutics, Inc.

Ticker: TRDA

Login to get an email when Entrada Therapeutics, Inc. files a report

Insider Title
Andrew J. Schwab 10% or greater ownership
Ansbert Gadicke 10% or greater ownership
Asset Management Investors Bv2014 Llc Mpm 10% or greater ownership
Asset Management Investors Bv2018 Llc Mpm 10% or greater ownership
Bernhardt G Zeiher Director
Biopharma Investments Iii, L.p. Redmile 10% or greater ownership
Bioventures 2014 (b), L.p. Mpm 10% or greater ownership
Bioventures 2014 Gp Llc Mpm 10% or greater ownership
Bioventures 2014 Llc Mpm 10% or greater ownership
Bioventures 2014, L.p. Mpm 10% or greater ownership
Bioventures 2018 (b), L.p. Mpm 10% or greater ownership
Bioventures 2018 Gp Llc Mpm 10% or greater ownership
Bioventures 2018 Llc Mpm 10% or greater ownership
Bioventures 2018, L.p. Mpm 10% or greater ownership
Bros. Advisors (gp) Llc Baker 10% or greater ownership
Bros. Advisors Lp Baker 10% or greater ownership
Carole Nuechterlein Director
Dipal Doshi CEO, Director
Felix Baker 10% or greater ownership
Finance Ltd Roche 10% or greater ownership
Gina Chapman Director
Group, Llc Redmile Director, 10% or greater ownership
Holding Ltd Roche 10% or greater ownership
Jeremy Green Director, 10% or greater ownership
John F Crowley Director
Julian Baker 10% or greater ownership
Kory James Wentworth Chief Financial Officer
Kush Parmar Director, 10% or greater ownership
Luke Evnin 10% or greater ownership
Mary Thistle Director
Natarajan Sethuraman President, Research Develop.
Nathan J Dowden President COO
Nerissa Kreher Chief Medical Officer
Opportunities I (gp), Llc 5am 10% or greater ownership
Opportunities I, L.p. 5am 10% or greater ownership
Partners V, Llc 5am 10% or greater ownership
Peter S Kim Director
Scott M Rocklage 10% or greater ownership
Todd Foley Director, 10% or greater ownership
Ventures V, L.p. 5am 10% or greater ownership